U.K.-based medical research center OpenBind has created a dataset designed to measure how potential drug molecules attach to disease‑related proteins. The dataset contains 800 different experiments generated through rapid molecular imaging and standardized data collection methods. Researchers can use this dataset to train OpenBind’s new AI model, enabling it to pinpoint promising drug candidates more quickly and accurately.
Expanding Drug Discovery
previous post
